Abstract CT034: Results from Phase 3 KEYLYNK-008: Pembrolizumab (pembro) with and Without Maintenance Olaparib (ola) after First-Line (1L) Pembro Plus Chemotherapy (chemo) for Metastatic Squamous Non-Small-cell Lung Cancer (Sqnsclc)
Cancer Research(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要